临研微客
Published by:
Beijing CTSLtd
Description
临研微客APP是一款专为临床试验行业人群打造的赚钱好帮手，时间自由、多劳多得！
接单便捷 自由规划
根据自主时间与雇主进行洽谈、接单、线上就可享受从接单到项目款项结算的一站式服务，让您在碎片时间，获取更多专业收益。
接单便捷 自由规划
根据自主时间与雇主进行洽谈、接单、线上就可享受从接单到项目款项结算的一站式服务，让您在碎片时间，获取更多专业收益。
Screenshots
临研微客 FAQ
-
Is 临研微客 free?
Yes, 临研微客 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 临研微客 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 临研微客 cost?
临研微客 is free.
-
What is 临研微客 revenue?
To get estimated revenue of 临研微客 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Belgium yet.
Ratings History
临研微客 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
临研微客 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
上善SSFC-为理财师提供资产研究服务
N/A
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
Coremed临床助手
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
金玉良研
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
微联盟
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
航伙伴
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
药试圈从业者
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
歌伦布
10亿用户的共享元宇宙电话本
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
医好康-管理版
|
Unlock
|
Unlock
|
0
|
|
4 weeks ago | |
天鹿园
|
Unlock
|
Unlock
|
0
|
|
10 months ago | |
Ai蹦蹦
|
Unlock
|
Unlock
|
0
|
|
1 year ago |
临研微客 Installs
Last 30 days
临研微客 Revenue
Last 30 days临研微客 Revenue and Downloads
Gain valuable insights into 临研微客 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Utilities
- Publisher
- Beijing CTSLtd
- Languages
- Chinese
- Recent release
- 1.0.5 (1 year ago )
- Released on
- Oct 10, 2022 (2 years ago )
- Also available in
- Poland , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , Italy , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Denmark , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , United Arab Emirates , Algeria , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel , India
- Last Updated
- 9 hours ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.